Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic cancer by blocking nf-κb activity

Digestive Diseases and Sciences

Volumn 55, Issue 4, 2010, Pages 1167-1176

  Matsuo, Yoichi ^a,b   Sawai, Hirozumi ^b   Ochi, Nobuo ^a,b   Yasuda, Akira ^b   Sakamoto, Masaki ^b   Takahashi, Hiroki ^b   Funahashi, Hitoshi ^b   Takeyama, Hiromitsu ^b   Guha, Sushovan ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Angiogenesis; NF B; Pancreatic cancer; Proteasome inhibitor

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEASOME INHIBITOR; VASCULOTROPIN; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; LEUPEPTIN; VASCULOTROPIN A;

ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; CELL DIVISION; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PANCREAS; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-8; LEUPEPTINS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PANCREAS; PANCREATIC NEOPLASMS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950356821     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0814-4     Document Type: Article

References (47)

1. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995;221:721-731. doi: 10.1097/00000658-199506000-00011 (discussion 731-733).
2. DB Evans JE Lee PW Pisters C Charnsangavej LM Ellis PJ Chiao R Lenzi JL Abbruzzese 1997 Advances in the diagnosis and treatment of adenocarcinoma of the pancreas Cancer Treat Res 90 109 125 1:STN:280:DyaK1c%2Fjtl2ltg%3D%3D 9367080
3. SM Pino HQ Xiong D McConkey JL Abbruzzese 2004 Novel therapies for pancreatic adenocarcinoma Curr Oncol Rep 6 199 206 10.1007/s11912-004-0050-1 10.1007/s11912-004-0050-1 15066231 (Pubitemid 39359487)
4. M Karin Y Cao FR Greten ZW Li 2002 NF-kappaB in cancer: from innocent bystander to major culprit Nat Rev Cancer 2 301 310 10.1038/nrc780 10.1038/nrc780 1:CAS:528:DC%2BD38XivFGqt7k%3D 12001991
5. MA Sovak RE Bellas DW Kim GJ Zanieski AE Rogers AM Traish GE Sonenshein 1997 Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer J Clin Invest 100 2952 2960 10.1172/JCI119848 10.1172/JCI119848 1:CAS:528:DyaK2sXotVyku7w%3D 9399940
6. RC Bargou F Emmerich D Krappmann K Bommert MY Mapara W Arnold HD Royer E Grinstein A Greiner C Scheidereit B Dorken 1997 Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells J Clin Invest 100 2961 2969 10.1172/JCI119849 10.1172/JCI119849 1:CAS:528:DyaK2sXotVyku70%3D 9399941 (Pubitemid 28022832)
7. W Wang JL Abbruzzese DB Evans L Larry KR Cleary PJ Chiao 1999 The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells Clin Cancer Res 5 119 127 1:CAS:528: DyaK1MXhtVShtLY%3D 9918209
8. HQ Xiong JL Abbruzzese E Lin L Wang L Zheng K Xie 2004 NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells Int J Cancer 108 181 188 10.1002/ijc.11562 10.1002/ijc.11562 1:CAS:528: DC%2BD3sXhtVWgu7zO 14639600 (Pubitemid 37541768)
9. AA Beg AS Baldwin Jr 1993 The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors Genes Dev 7 2064 2070 10.1101/gad.7.11.2064 10.1101/gad.7.11.2064 1:CAS:528:DyaK2cXisFKktw%3D%3D 8224838
10. IM Verma JK Stevenson EM Schwarz D Van Antwerp S Miyamoto 1995 Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation Genes Dev 9 2723 2735 10.1101/gad.9.22.2723 10.1101/gad.9.22.2723 1:CAS:528:DyaK2MXpslOmsb0%3D 7590248
11. VJ Palombella OJ Rando AL Goldberg T Maniatis 1994 The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B Cell 78 773 785 10.1016/S0092-8674(94)90482-0 10.1016/S0092-8674(94)90482-0 1:CAS:528: DyaK2cXmtVegsLg%3D 8087845 (Pubitemid 24294453)
12. EB Traenckner S Wilk PA Baeuerle 1994 A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B EMBO J 13 5433 5441 1:CAS:528:DyaK2MXktFWjsLc%3D 7957109
13. LA Liotta EC Kohn 2001 The microenvironment of the tumour-host interface Nature 411 375 379 10.1038/35077241 10.1038/35077241 1:CAS:528: DC%2BD3MXktVSjs78%3D 11357145 (Pubitemid 32467047)
14. F Bussolino A Mantovani G Persico 1997 Molecular mechanisms of blood vessel formation Trends Biochem Sci 22 251 256 10.1016/S0968-0004(97)01074-8 10.1016/S0968-0004(97)01074-8 1:CAS:528:DyaK2sXks1yksL8%3D 9255066 (Pubitemid 27310945)
15. J Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 4 6 10.1093/jnci/82.1.4 10.1093/jnci/82.1.4 1:STN:280:DyaK3c%2FnvF2qug%3D%3D 1688381
16. J Folkman 1986 How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture Cancer Res 46 467 473 1:CAS:528:DyaL28Xos1aiug%3D%3D 2416426
17. Matsuo Y, Sawai H, Ochi N, et al. Interleukin-1 alpha secreted by pancreatic cancer cells promotes angiogenesis and its therapeutic implications. J Surg Res. (in press).
18. Y Matsuo H Sawai H Funahashi H Takahashi M Sakamoto M Yamamoto Y Okada T Hayakawa T Manabe 2004 Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential Pancreas 28 344 352 10.1097/00006676-200404000-00025 10.1097/00006676-200404000-00025 1:CAS:528:DC%2BD2cXjslCntb8%3D 15084984 (Pubitemid 38437336)
19. ST Nawrocki CJ Bruns MT Harbison RJ Bold BS Gotsch JL Abbruzzese P Elliott J Adams DJ McConkey 2002 Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts Mol Cancer Ther 1 1243 1253 1:CAS:528:DC%2BD3sXmtFamuw%3D%3D 12516957
20. ST Nawrocki B Sweeney-Gotsch R Takamori DJ McConkey 2004 The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts Mol Cancer Ther 3 59 70 1:CAS:528: DC%2BD2cXntFaisg%3D%3D 14749476
21. ET Bishop GT Bell S Bloor IJ Broom NF Hendry DN Wheatley 1999 An in vitro model of angiogenesis: basic features Angiogenesis 3 335 344 10.1023/A:1026546219962 10.1023/A:1026546219962 1:STN:280:DC%2BD3svlsFagtQ%3D%3D 14517413
22. T Osugi Y Oshima Y Fujio M Funamoto A Yamashita S Negoro K Kunisada M Izumi Y Nakaoka H Hirota M Okabe K Yamauchi-Takihara I Kawase T Kishimoto 2002 Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart J Biol Chem 277 6676 6681 10.1074/jbc.M108246200 10.1074/jbc.M108246200 1:CAS:528:DC%2BD38XhvFyqtr8%3D 11744720 (Pubitemid 34968469)
23. J Folkman 1997 Angiogenesis and angiogenesis inhibition: an overview EXS 79 1 8 1:STN:280:DyaK2s7lsFGiug%3D%3D 9002217
24. LF Brown B Berse RW Jackman K Tognazzi EJ Manseau DR Senger HF Dvorak 1993 Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract Cancer Res 53 4727 4735 1:CAS:528:DyaK2cXivVCjtw%3D%3D 8402650 (Pubitemid 23304407)
25. J Itakura T Ishiwata H Friess H Fujii Y Matsumoto MW Buchler M Korc 1997 Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression Clin Cancer Res 3 1309 1316 1:CAS:528:DyaK2sXls1Smtrk%3D 9815813
26. Q Shi X Le JL Abbruzzese Z Peng CN Qian H Tang Q Xiong B Wang XC Li K Xie 2001 Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma Cancer Res 61 4143 4154 1:CAS:528:DC%2BD3MXktVWqt7o%3D 11358838
27. Q Shi JL Abbruzzese S Huang IJ Fidler Q Xiong K Xie 1999 Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic Clin Cancer Res 5 3711 3721 1:CAS:528:DyaK1MXotV2gt7c%3D 10589791
28. K Xie 2001 Interleukin-8 and human cancer biology Cytokine Growth Factor Rev 12 375 391 10.1016/S1359-6101(01)00016-8 10.1016/S1359-6101(01)00016-8 1:CAS:528:DC%2BD3MXmsFChtLg%3D 11544106 (Pubitemid 32851749)
29. E Tischer R Mitchell T Hartman M Silva D Gospodarowicz JC Fiddes JA Abraham 1991 The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing J Biol Chem 266 11947 11954 1:CAS:528:DyaK38XhtVSgtbk%3D 1711045
30. M Ema S Taya N Yokotani K Sogawa Y Matsuda Y Fujii-Kuriyama 1997 A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development Proc Natl Acad Sci USA 94 4273 4278 10.1073/pnas.94.9.4273 10.1073/pnas.94.9.4273 1:CAS:528:DyaK2sXjtVyitbY%3D 9113979 (Pubitemid 27194231)
31. I Flamme T Frohlich M von Reutern A Kappel A Damert W Risau 1997 HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels Mech Dev 63 51 60 10.1016/S0925-4773(97)00674-6 10.1016/S0925-4773(97)00674-6 1:CAS:528:DyaK2sXjvVKisro%3D 9178256 (Pubitemid 27214502)
32. I Stein A Itin P Einat R Skaliter Z Grossman E Keshet 1998 Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia Mol Cell Biol 18 3112 3119 1:CAS:528:DyaK1cXjsFSkur4%3D 9584152
33. G Akiri D Nahari Y Finkelstein SY Le O Elroy-Stein BZ Levi 1998 Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription Oncogene 17 227 236 10.1038/sj.onc.1202019 10.1038/sj.onc.1202019 1:CAS:528:DyaK1cXltFKisbo%3D 9674707
34. X Le Q Shi B Wang Q Xiong C Qian Z Peng XC Li H Tang JL Abbruzzese K Xie 2000 Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma J Interferon Cytokine Res 20 935 946 10.1089/10799900050198372 10.1089/10799900050198372 1:CAS:528: DC%2BD3cXosl2jtbo%3D 11096450
35. Q Shi X Le B Wang JL Abbruzzese Q Xiong Y He K Xie 2001 Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells Oncogene 20 3751 3756 10.1038/sj.onc.1204500 10.1038/sj.onc.1204500 1:CAS:528:DC%2BD3MXltVKnsbw%3D 11439338 (Pubitemid 32624967)
36. S Huang CA Pettaway H Uehara CD Bucana IJ Fidler 2001 Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis Oncogene 20 4188 4197 10.1038/sj.onc.1204535 10.1038/sj.onc.1204535 1:CAS:528:DC%2BD3MXls1WltbY%3D 11464285 (Pubitemid 32762193)
37. Sawai H, Funahashi H, Okada Y, et al. Interleukin-1alpha enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells. Med Sci Monit. 2005;11:BR343-350.
38. Y Mizukami WS Jo EM Duerr M Gala J Li X Zhang MA Zimmer O Iliopoulos LR Zukerberg Y Kohgo MP Lynch BR Rueda DC Chung 2005 Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells Nat Med 11 992 997 1:CAS:528:DC%2BD2MXpslelurY%3D 16127434
39. BN Fahy MG Schlieman MM Mortenson S Virudachalam RJ Bold 2005 Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib Cancer Chemother Pharmacol 56 46 54 10.1007/s00280-004-0944-5 10.1007/s00280-004-0944-5 1:CAS:528: DC%2BD2MXjvFKrsbg%3D 15791457 (Pubitemid 41201755)
40. QG Dong GM Sclabas S Fujioka C Schmidt B Peng T Wu MS Tsao DB Evans JL Abbruzzese TJ McDonnell PJ Chiao 2002 The function of multiple IkappaB: NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis Oncogene 21 6510 6519 10.1038/sj.onc.1205848 10.1038/sj.onc.1205848 1:CAS:528:DC%2BD38XmvVOqsbk%3D 12226754 (Pubitemid 35155455)
41. A Arlt J Vorndamm M Breitenbroich UR Folsch H Kalthoff WE Schmidt H Schafer 2001 Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin Oncogene 20 859 868 10.1038/sj.onc.1204168 10.1038/sj.onc.1204168 1:CAS:528:DC%2BD3MXhvVersL4%3D 11314019 (Pubitemid 32198179)
42. SR Alberts NR Foster RF Morton J Kugler P Schaefer M Wiesenfeld TR Fitch P Steen GP Kim S Gill 2005 PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study Ann Oncol 16 1654 1661 10.1093/annonc/mdi324 10.1093/annonc/mdi324 1:STN:280:DC%2BD2MvpvFKiuw%3D%3D 16085692 (Pubitemid 41510140)
43. A Arlt A Gehrz S Müerköster J Vorndamm ML Kruse UR Fölsch H Schäfer 2003 Role of NF-kappaB and Akt/PI3 K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death Oncogene 22 3243 3251 10.1038/sj.onc.1206390 10.1038/sj.onc.1206390 1:CAS:528: DC%2BD3sXjvFaksLw%3D 12761494 (Pubitemid 36712936)
44. Z Tong AB Kunnumakkara H Wang Y Matsuo P Diagaradjane KB Harikumar V Ramachandran B Sung A Chakraborty RS Bresalier C Logsdon BB Aggarwal S Krishnan S Guha 2008 Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer Cancer Res 68 6100 6108 10.1158/0008-5472.CAN-08-0540 10.1158/0008-5472.CAN-08-0540 1:CAS:528: DC%2BD1cXpt1Sqtbw%3D 18676832
45. MN Wente G Eibl HA Reber H Friess MW Büchler OJ Hines 2005 The proteasome inhibitor MG132 induces apoptosis in human pancreatic cancer cells Oncol Rep 14 1635 1638 1:CAS:528:DC%2BD2MXhtlGns7%2FF 16273269
46. XM Fan BC Wong WP Wang XM Zhou CH Cho ST Yuen SY Leung MC Lin HF Kung SK Lam 2001 Inhibition of proteasome function induced apoptosis in gastric cancer Int J Cancer 93 481 488 10.1002/ijc.1373 10.1002/ijc.1373 1:CAS:528: DC%2BD3MXlsVCntr0%3D 11477551 (Pubitemid 32701406)
47. Y Zhang Y Shi X Li R Du G Luo L Xia W Du B Chen H Zhai K Wu D Fan 2008 Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp Cancer Biol Ther 7 540 546 1:CAS:528:DC%2BD1cXhtVSktL3I 18296917